AI Article Synopsis

  • A rare case of a gastric gastrointestinal stromal tumor (GIST) was reported in a 58-year-old male, who had a history of duodenal GIST resected 9 years prior.
  • Following anemia-related admission, a CT scan revealed a large stomach tumor over 10 cm, leading to extensive surgical intervention including subtotal gastrectomy and splenectomy.
  • The pathological examination confirmed the tumor as a high-risk gastric GIST, and the patient has been successfully treated with imatinib since surgery, with no recurrence observed in the last 2 years.

Article Abstract

Multiple sporadic gastrointestinal stromal tumor(GIST)are rare, except for those restricted to von Recklinghausen disease or hereditary conditions.We reported a case of a gastric GIST resected 9 years after the resection of a duodenal GIST.The patient was a 58-year-old male who had been followed-up with computed tomography scans after pancreatoduodenectomy for a duodenal GIST when he was 49-years-old.The patient was admitted to our hospital for anemia examination.A CT scan detected a tumor in the stomach, with a diameter of over 10 cm, and necrosis.Esophagogastroduodenoscopy revealed the presence of a delle on the gastric SMT.Due to suspected invasion of the spleen and left diaphragm by the tumor, we performed subtotal gastrectomy with splenectomy and left diaphragm segmental resection.In the pathological diagnosis, the tumor was diagnosed as a gastric GIST, because the cell type of the tumor was spindle and tested positive for c-kit.Based on the tumor size and mitotic count, the patient was diagnosed with high-risk GIST by the modified-Fletcher classification, and imatinib 400mg/day was administered.There have been no signs of recurrence for 2 years since the operation.

Download full-text PDF

Source

Publication Analysis

Top Keywords

gastrointestinal stromal
12
years resection
8
resection duodenal
8
gastric gist
8
left diaphragm
8
tumor
6
[gastric gastrointestinal
4
stromal tumor
4
tumor appearing
4
appearing years
4

Similar Publications

The cellular components of the tumor microenvironment (TME) comprise cancer cells and nonmalignant cells including stromal and immune cells. Exosomes are extracellular vesicles secreted by various types of cells that play a crucial role in intercellular communications within TME. The main goal of this study was to elucidate how exosomes of macrophage cells treated with doxorubicin (DOX) and DOX-loaded cyclodextrin-based nanosponges (DOX-CDNSs), affect melanoma cancer cell proliferation.

View Article and Find Full Text PDF

m6A demethylation of NNMT in CAFs promotes gastric cancer progression by enhancing macrophage M2 polarization.

Cancer Lett

December 2024

Digestive Diseases Center, Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, 518107, China. Electronic address:

Cancer associated fibroblasts (CAFs) are the predominant stromal cells in the tumor microenvironment of gastric cancer (GC), interacting with both immune and tumor cells to drive cancer progression. However, the precise link between these interactions and their potential as therapeutic targets remains poorly understood. In this study, we identified for the first time that nicotinamide N-methyltransferase (NNMT) derived from CAFs promoted M2 macrophage polarization, which, in turn, facilitated the proliferation and migration of GC cells.

View Article and Find Full Text PDF

Gastrointestinal stromal tumors (GIST) are rare in the rectum. These usually present with symptoms produced by compression of pelvic organs or bleeding. Surgery is the treatment of choice, however, at times the surgery can be mutilating and organ preservation may not be possible.

View Article and Find Full Text PDF

Pharmacokinetic Interaction between Imatinib and Tacrolimus in Rats.

Curr Drug Metab

December 2024

Department of Pharmacy, the Fourth Hospital of Hebei Medical University, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, China.

Objective: Tacrolimus, a calcineurin inhibitor (CNI), is the first-line treatment for chronic myeloid leukemia (CML) and advanced gastrointestinal stromal tumors (GIST). Imatinib and tacrolimus are both substrates of the hepatic enzymes CYP3A4/5 and efflux transporter P-gp, so drug-drug interactions may occur during their co-administration treatment. Therefore, this study aimed to evaluate the pharmacokinetic interaction between imatinib and tacrolimus in rats.

View Article and Find Full Text PDF

An Unusual Diagnosis of Rectosigmoid Leiomyoma in an Adult: A Rare Case Report.

Clin Med Insights Case Rep

December 2024

Department of Gastroenterology, Faculty of Medicine, University of Balamand, Beirut, Lebanon.

Leiomyomas are uncommon tumors of the gastrointestinal system, representing around 0.03% to 0.05% of all rectal tumors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!